Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...

Dear Friends:

Thank you for your interest in – and support of -- the Israel Cancer Research Fund (ICRF).  We are North America’s largest non-profit dedicated to funding Israeli cancer research.

I am happy to report that the rate of discovery in cancer research is accelerating – and nowhere more than in Israel. Israel is a major source of innovation in the understanding and treatment of cancer. Many of Israel’s most promising cancer research investigations have been funded by ICRF.

As a result of our careful proposal review process, we have provided funding that has helped to propel the careers of some of the world’s leading cancer researchers, including Professor Howard Cedar and Nobel Prize winning scientists Drs. Avram Hershko and Aaron Ciechanover, to name just a few.

Looking to the future, we are particularly excited by our partnership with the City of Hope in Los Angeles, which will support high-potential research collaborations while promoting the exchange of ideas and information between exceptional cancer researchers in the United States and Israel.

To me, the case for support of ICRF is clear-cut and compelling. Israeli cancer research is world-class and, due to lower overhead costs and ICRF’s ability to directly fund its grantees, cost-effective.  Or as my financial services friends might put it, with ICRF you get both growth and value.

A prominent Israeli cancer researcher was once asked, “When will there be a cure for cancer?”  His response: “No money, never. Some money, one day. More money, sooner.”

But know, too, that even as we push smartly and energetically forward towards cures, we are making important advances that are benefitting millions of families now.  From Velcade to Doxil to Gleevec, ICRF scientists have made essential contributions to the development of many groundbreaking drugs, giving millions of families, including mine, the greatest gift of all – more time together.

Unfortunately, every year, ICRF receives more promising research proposals than we have dollars to fund. Our goal: to make sure that no deserving cancer research project in Israel goes unfunded. Ever.  With your help, we can make that happen.

Sincerely,

Rob Densen
President